Carregant...
Bi-directional drug-microbiome interactions of anti-diabetics
Type 2 diabetes (T2D) has become a global epidemic. Although several drugs are available to manage T2D, problems associated with person-to-person variability in drug efficacy and potential side-effects remain unresolved. Owing to the emerging role of the gut microbiome in obesity and T2D, the intera...
Guardat en:
| Publicat a: | EBioMedicine |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354569/ https://ncbi.nlm.nih.gov/pubmed/30553752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.11.046 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|